Suppr超能文献

妇女健康倡议饮食改良试验干预期及干预后期的癌症发病率与死亡率。

Cancer incidence and mortality during the intervention and postintervention periods of the Women's Health Initiative dietary modification trial.

作者信息

Thomson Cynthia A, Van Horn Linda, Caan Bette J, Aragaki Aaron K, Chlebowski Rowan T, Manson JoAnn E, Rohan Thomas E, Tinker Lesley F, Kuller Lewis H, Hou Lifang, Lane Dorothy S, Johnson Karen C, Vitolins Mara Z, Prentice Ross L

机构信息

Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona.

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

出版信息

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2924-35. doi: 10.1158/1055-9965.EPI-14-0922. Epub 2014 Sep 25.

Abstract

BACKGROUND

The Women's Health Initiative (WHI) low-fat (20% kcal) dietary modification (DM) trial (1993-2005) demonstrated a nonsignificant reduction in breast cancer, a nominally significant reduction in ovarian cancer, and no effect on other cancers (mean 8.3 years intervention). Consent to nonintervention follow-up was 83% (n = 37,858). This analysis was designed to assess postintervention cancer risk in women randomized to the low-fat diet (40%) versus usual diet comparison (60%).

METHODS

Randomized, controlled low-fat diet intervention for prevention of breast and colorectal cancers conducted in 48,835 postmenopausal U.S. women, ages 50 to 79 years at 40 U.S. sites. Outcomes included total invasive cancer, breast cancer, and colorectal cancer, and cancer-specific and overall mortality.

RESULTS

There were no intervention effects on invasive breast or colorectal cancer, other cancers, or cancer-specific or overall mortality during the postintervention period or the combined intervention and follow-up periods. For invasive breast cancer, the hazard ratios (HR) and 95% confidence interval (CI) were 0.92 (0.84-1.01) during intervention, 1.08 (0.94-1.24) during the postintervention period, and 0.97 (0.89-1.05) during cumulative follow-up. A reduced risk for estrogen receptor positive/progesterone receptor-negative tumors was demonstrated during follow-up. In women with higher baseline fat intake (quartile), point estimates of breast cancer risk were HR, 0.76 (95% CI, 0.62-0.92) during intervention versus HR, 1.11 (95% CI, 0.84-1.4) during postintervention follow-up (Pdiff = 0.03).

CONCLUSIONS

Dietary fat intake increased postintervention in intervention women; no long-term reduction in cancer risk or mortality was shown in the WHI DM trial.

IMPACT

Dietary advisement to reduce fat for cancer prevention after menopause generally was not supported by the WHI DM trial.

摘要

背景

妇女健康倡议(WHI)低脂(占热量的20%)饮食调整(DM)试验(1993 - 2005年)显示,乳腺癌风险有不显著降低,卵巢癌风险有名义上的显著降低,对其他癌症无影响(平均干预8.3年)。非干预随访的同意率为83%(n = 37,858)。本分析旨在评估随机分配至低脂饮食组(40%)与常规饮食对照组(60%)的女性在干预后的癌症风险。

方法

在美国40个地点对48,835名年龄在50至79岁的绝经后美国女性进行了预防乳腺癌和结直肠癌的随机对照低脂饮食干预。结局指标包括总的浸润性癌症、乳腺癌和结直肠癌,以及癌症特异性死亡率和总死亡率。

结果

在干预后时期或干预与随访合并时期,对浸润性乳腺癌或结直肠癌、其他癌症、癌症特异性死亡率或总死亡率均无干预效果。对于浸润性乳腺癌,干预期间风险比(HR)及95%置信区间(CI)为0.92(0.84 - 1.01),干预后时期为1.08(0.94 - 1.24),累积随访期间为0.97(0.89 - 1.05)。随访期间显示雌激素受体阳性/孕激素受体阴性肿瘤的风险降低。在基线脂肪摄入量较高(四分位数)的女性中,干预期间乳腺癌风险的点估计值为HR,0.76(95%CI,0.62 - 0.92),干预后随访期间为HR,1.11(95%CI,0.84 - 1.4)(P差值 = 0.03)。

结论

干预组女性在干预后饮食脂肪摄入量增加;WHI饮食调整试验未显示癌症风险或死亡率有长期降低。

影响

WHI饮食调整试验总体上不支持绝经后为预防癌症而减少脂肪摄入的饮食建议。

相似文献

引用本文的文献

5
Developing dietary interventions as therapy for cancer.开发饮食干预作为癌症治疗方法。
Nat Rev Cancer. 2022 Aug;22(8):452-466. doi: 10.1038/s41568-022-00485-y. Epub 2022 May 25.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验